F3 and cancer: Cancer cells are known to express procoagulant molecules, such as tissue factor (TF), that possess the capacity to activate coagulation mechanisms directly.9 Furthermore, tumor cells can stimulate cytokine production, which in turn activates coagulation processes and fosters rapid cancer development.10-13 During the evolution of malignancies, the expression of P-selectin is enhanced.